Analysts' average 12-month price target for Satellos Bioscience Common Stock is $18.
Get informed when a big investor buys or sells
+ Follow$9.05
2 analysts in the last 4 months
High: $18 | Low: $18
No recommendations in the last 4 months.
The latest target price for MSLE is $18. Investors often review this figure alongside Satellos Bioscience Common Stock's historical trend and sector peers before judging valuation or financial health.
Satellos Bioscience Common Stock trades near $9.05 while the consensus target sits at $18 (98.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.
After noting MSLE's target price ($18), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.